Today’s Headline of the Day is a two-fer.
1. “Red Wine Rivals Diabetes Drug in Lab Tests,” says a February 1 headline in Wine Spectator, going on to say, “Researchers working in biotechnology laboratories in Vienna have found that red wine contains favorable levels of a chemical [rosiglitazone, marketed under the name Avandia] currently used to treat type 2 diabetes patients.” Neither the article nor the study it describes mentions that that drug has received some unflattering attention from government regulators and others. [Thanks to Ivan Oransky for bringing this to our attention.]
2. “Research suggests V8 100% vegetable juice can help people meet key dietary guidelines,” says the headline in a February 3 press release. The document concludes with this assurance: “The studies were supported in part by Campbell Soup Company … a global manufacturer and marketer of high-quality foods … including “Campbell’s,” “Pepperidge Farm,” “Arnott’s” and “V8.” [Thanks to IanVisits for bringing this to our attention.]
(Our Headline of the Day calls out research that may or may not be worth your attention.)